BR112015027992A2 - uso de ácido petroselínico para combater desordens estéticas da figura do corpo - Google Patents

uso de ácido petroselínico para combater desordens estéticas da figura do corpo

Info

Publication number
BR112015027992A2
BR112015027992A2 BR112015027992A BR112015027992A BR112015027992A2 BR 112015027992 A2 BR112015027992 A2 BR 112015027992A2 BR 112015027992 A BR112015027992 A BR 112015027992A BR 112015027992 A BR112015027992 A BR 112015027992A BR 112015027992 A2 BR112015027992 A2 BR 112015027992A2
Authority
BR
Brazil
Prior art keywords
petroselinic acid
combat
aesthetic disorders
taurine
zinc
Prior art date
Application number
BR112015027992A
Other languages
English (en)
Inventor
Gueniche Audrey
Bru Carole
Mahe Yann
Original Assignee
Oreal
Nestec Sa
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Oreal, Nestec Sa filed Critical Oreal
Publication of BR112015027992A2 publication Critical patent/BR112015027992A2/pt

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/185—Acids; Anhydrides, halides or salts thereof, e.g. sulfur acids, imidic, hydrazonic or hydroximic acids
    • A61K31/19—Carboxylic acids, e.g. valproic acid
    • A61K31/20—Carboxylic acids, e.g. valproic acid having a carboxyl group bound to a chain of seven or more carbon atoms, e.g. stearic, palmitic, arachidic acids
    • A61K31/201—Carboxylic acids, e.g. valproic acid having a carboxyl group bound to a chain of seven or more carbon atoms, e.g. stearic, palmitic, arachidic acids having one or two double bonds, e.g. oleic, linoleic acids
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/01—Hydrocarbons
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/13—Amines
    • A61K31/145—Amines having sulfur, e.g. thiurams (>N—C(S)—S—C(S)—N< and >N—C(S)—S—S—C(S)—N<), Sulfinylamines (—N=SO), Sulfonylamines (—N=SO2)
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/185—Acids; Anhydrides, halides or salts thereof, e.g. sulfur acids, imidic, hydrazonic or hydroximic acids
    • A61K31/19—Carboxylic acids, e.g. valproic acid
    • A61K31/195—Carboxylic acids, e.g. valproic acid having an amino group
    • A61K31/197—Carboxylic acids, e.g. valproic acid having an amino group the amino and the carboxyl groups being attached to the same acyclic carbon chain, e.g. gamma-aminobutyric acid [GABA], beta-alanine, epsilon-aminocaproic acid or pantothenic acid
    • A61K31/198—Alpha-amino acids, e.g. alanine or edetic acid [EDTA]
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/21—Esters, e.g. nitroglycerine, selenocyanates
    • A61K31/215—Esters, e.g. nitroglycerine, selenocyanates of carboxylic acids
    • A61K31/22—Esters, e.g. nitroglycerine, selenocyanates of carboxylic acids of acyclic acids, e.g. pravastatin
    • A61K31/23—Esters, e.g. nitroglycerine, selenocyanates of carboxylic acids of acyclic acids, e.g. pravastatin of acids having a carboxyl group bound to a chain of seven or more carbon atoms
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/28—Compounds containing heavy metals
    • A61K31/315—Zinc compounds
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K33/00—Medicinal preparations containing inorganic active ingredients
    • A61K33/24—Heavy metals; Compounds thereof
    • A61K33/30—Zinc; Compounds thereof
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K8/00—Cosmetics or similar toiletry preparations
    • A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
    • A61K8/30—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds
    • A61K8/33—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds containing oxygen
    • A61K8/36—Carboxylic acids; Salts or anhydrides thereof
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K8/00—Cosmetics or similar toiletry preparations
    • A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
    • A61K8/96—Cosmetics or similar toiletry preparations characterised by the composition containing materials, or derivatives thereof of undetermined constitution
    • A61K8/97—Cosmetics or similar toiletry preparations characterised by the composition containing materials, or derivatives thereof of undetermined constitution from algae, fungi, lichens or plants; from derivatives thereof
    • A61K8/9783—Angiosperms [Magnoliophyta]
    • A61K8/9789—Magnoliopsida [dicotyledons]
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism
    • A61P3/04—Anorexiants; Antiobesity agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61Q—SPECIFIC USE OF COSMETICS OR SIMILAR TOILETRY PREPARATIONS
    • A61Q19/00—Preparations for care of the skin
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61Q—SPECIFIC USE OF COSMETICS OR SIMILAR TOILETRY PREPARATIONS
    • A61Q19/00—Preparations for care of the skin
    • A61Q19/06—Preparations for care of the skin for countering cellulitis
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K2800/00—Properties of cosmetic compositions or active ingredients thereof or formulation aids used therein and process related aspects
    • A61K2800/80—Process related aspects concerning the preparation of the cosmetic composition or the storage or application thereof
    • A61K2800/92—Oral administration

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Epidemiology (AREA)
  • Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Birds (AREA)
  • Emergency Medicine (AREA)
  • Dermatology (AREA)
  • Engineering & Computer Science (AREA)
  • Biotechnology (AREA)
  • Inorganic Chemistry (AREA)
  • Mycology (AREA)
  • Microbiology (AREA)
  • Botany (AREA)
  • Hematology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Diabetes (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Child & Adolescent Psychology (AREA)
  • Obesity (AREA)
  • General Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)

Abstract

resumo uso de ácido petroselínico para combater desordens estéticas da figura do corpo a presente invenção se refere ao uso cosmético, por administração oral, de ácido petroselínico ou de uma combinação de ingredientes ativos compreendendo pelo menos ácido petroselínico e pelo menos um composto escolhido a partir de zinco, taurina, um dos sais do mesmo, licopeno e as misturas dos mesmos, e preferencialmente pelo menos taurina ou gluconato de zinco e, mais preferencialmente ainda, pelo menos taurina e gluconato de zinco, com o objetivo de combater desordens estéticas da figura de corpo ligada a modificações no tecido adiposo. 1/1
BR112015027992A 2013-05-07 2014-05-07 uso de ácido petroselínico para combater desordens estéticas da figura do corpo BR112015027992A2 (pt)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
FR1354186A FR3005409B1 (fr) 2013-05-07 2013-05-07 Utilisation d'acide petroselinique pour lutter contre les desordres esthetiques de la silhouette
PCT/IB2014/061264 WO2014181267A1 (fr) 2013-05-07 2014-05-07 Utilisation d'acide petroselinique pour lutter contre les desordres esthetiques de la silhouette

Publications (1)

Publication Number Publication Date
BR112015027992A2 true BR112015027992A2 (pt) 2017-09-12

Family

ID=49274744

Family Applications (1)

Application Number Title Priority Date Filing Date
BR112015027992A BR112015027992A2 (pt) 2013-05-07 2014-05-07 uso de ácido petroselínico para combater desordens estéticas da figura do corpo

Country Status (7)

Country Link
US (1) US20160074353A1 (pt)
EP (1) EP2994101A1 (pt)
CN (1) CN105377226B (pt)
BR (1) BR112015027992A2 (pt)
CA (1) CA2911394A1 (pt)
FR (1) FR3005409B1 (pt)
WO (1) WO2014181267A1 (pt)

Families Citing this family (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
FR3030253B1 (fr) * 2014-12-18 2018-03-02 Nutricos Technologies Composition pour ameliorer l'aspect cellulitique de la peau
FR3080769B1 (fr) * 2018-05-04 2020-10-16 Soc Dexploitation De Produits Pour Les Industries Chimiques Seppic Utilisation orale d'huile de graines d'au moins une plante ombellifere pour un effet apaisant des peaux reactives
CN110559222B (zh) * 2019-05-14 2021-11-26 东方爱堡(北京)母婴健康科技有限公司 一种保湿抗氧化凝露及其制备方法
CN111821209B (zh) * 2020-08-20 2023-04-28 中国科学院华南植物园 一种复配型天然美白抗皱组合物和应用
CN115105492B (zh) * 2021-03-17 2023-08-25 南方医科大学南方医院 岩芹酸的新用途

Family Cites Families (11)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
FR2725370B1 (fr) * 1994-10-07 1997-06-06 Oreal Composition cosmetique ou dermatologique contenant une huile riche en acide petroselinique
US6262109B1 (en) * 1995-12-22 2001-07-17 Henkel Corporation Methods of preventing and/or treating high serum levels of cholesterol and/or lipids
EP0888773A1 (fr) * 1997-07-05 1999-01-07 Societe Des Produits Nestle S.A. Utilisation de l'acide pétrosélinique pour le traitement des inflammations des tissus superficiels
CN1406131A (zh) * 2000-12-25 2003-03-26 株式会社资生堂 活化交感神经的香料组合物
AU2003218834A1 (en) * 2002-03-11 2003-09-22 General Nutrition Investment Company Methods for the treatment and prevention of overweight in mammals
DE10325159A1 (de) * 2002-06-05 2003-12-18 Grazyna Ziegler-Janoschka Mittel zur äußerlichen Anwendung beim Menschen
JP3769267B2 (ja) * 2002-12-05 2006-04-19 順一 有田 亜鉛増強食品及びその製造方法
JP2005126405A (ja) * 2003-10-25 2005-05-19 Sadami Ishibashi 肥満防止剤
CN101453914A (zh) * 2006-04-13 2009-06-10 凯米迪卡有限公司 治疗代谢功能紊乱的番茄红素
CN101265177A (zh) * 2007-03-16 2008-09-17 中国医学科学院药物研究所 洋芫荽子酸类化合物
FR2952304B1 (fr) * 2009-11-12 2012-01-13 Silab Sa Principe actif cosmetique amincissant issu des fruits de la coriandre et de l'oranger doux, compositions cosmetiques l'incluant et utilisation

Also Published As

Publication number Publication date
US20160074353A1 (en) 2016-03-17
FR3005409B1 (fr) 2016-08-19
FR3005409A1 (fr) 2014-11-14
EP2994101A1 (fr) 2016-03-16
CN105377226B (zh) 2019-10-25
CA2911394A1 (fr) 2014-11-13
CN105377226A (zh) 2016-03-02
WO2014181267A1 (fr) 2014-11-13

Similar Documents

Publication Publication Date Title
BR112013022495A2 (pt) formulação farmacêutica aquosa de tapentadol para administração oral
BR112015027282A8 (pt) formulação líquida e kit compreendendo fenfluramina, e usos da mesma no tratamento de síndrome de dravet
BR112015022197A8 (pt) uso de um composto para fabricação de um medicamento ou composição farmacêutica para o tratamento de cataplexia
BR112015022972A2 (pt) composição farmacêutica de cloridrato de s-cetamina
EA201591004A1 (ru) Производные бороновой кислоты и их терапевтическое применение
BR112015025961A2 (pt) composto, composição cosmética ou farmacêutica, e, uso de um composto
MX349594B (es) Composicion para uso cosmetico adecuada para producir un efecto de pigmentacion sobre el cabello.
BR112015015898A8 (pt) composição farmacêutica de solução sólida, e, uso de uma composição farmacêutica
BR112015027992A2 (pt) uso de ácido petroselínico para combater desordens estéticas da figura do corpo
ES2397889A1 (es) PÉPTIDOS MODULADORES DE PGC-1Alfa.
BR112015022514A2 (pt) composições que compreendem selênio e uso das mesmas para o tratamento e prevenção de doença ou condições associadas à disfunção mitocondrial
AR084932A1 (es) Composicion oftalmica que comprende un androgeno y su uso para la fabricacion de un medicamento util para el tratamiento de una enfermedad ocular resultante de una deficiencia androgenica
BR112014011481A2 (pt) hidrolisado de colágeno e seu uso
EA201690183A1 (ru) Замещенные пиразолопиридинамины
BR112016003082A8 (pt) uso da tropoelastina na produção de um medicamento para cicatrização de uma ferida ou para melhora da reepitelização de uma ferida
BR112016013754A2 (pt) Recaptação de serotonina-norepinefrina inibidores (irsns) e combinações dos ligantes do receptor sigma
WO2012161497A3 (ko) 보습능이 우수한 펩타이드 유도체 및 이의 용도
BR112016007238A2 (pt) tienouracilcarboxamidas cíclicas e sua utilização
UY33568A (es) Compuestos que interactuan con proteina reguladora de glucocinasa para el tratamiento de diabetes.
BR112015027991A2 (pt) ácido petroselínico ou combinação de ingredientes ativos, compreendendo pelo menos ácido petroselínico para promover a perda de peso e/ou manutenção de peso
BR112013026933A2 (pt) uso de uma combinação de pelo menos um carotenoide
BR112014024033A8 (pt) Formulação vesicular, método para o tratamento da rosácea e uso de um ou mais fosfo, sulfolipídios e surfactantes
EA201591180A1 (ru) Составы ингибитора lfa-1
BR112015017381A2 (pt) agentes analgésicos oculares tópicos
BR112015014109A2 (pt) preparação cosmética ou dermatológica; e uso de sais de zinco de ácidos carboxílicos, em combinação com um ou mais compostos de eficácia antimicrobiana e/ou antiperspirante

Legal Events

Date Code Title Description
B07D Technical examination (opinion) related to article 229 of industrial property law [chapter 7.4 patent gazette]
B06F Objections, documents and/or translations needed after an examination request according [chapter 6.6 patent gazette]
B07B Technical examination (opinion): publication cancelled [chapter 7.2 patent gazette]
B06U Preliminary requirement: requests with searches performed by other patent offices: procedure suspended [chapter 6.21 patent gazette]
B25A Requested transfer of rights approved

Owner name: L'OREAL (FR) ; SOCIETE DES PRODUITS NESTLE S.A. (C

Owner name: L'OREAL (FR) ; SOCIETE DES PRODUITS NESTLE S.A. (CH)

B06A Patent application procedure suspended [chapter 6.1 patent gazette]
B07A Application suspended after technical examination (opinion) [chapter 7.1 patent gazette]
B09B Patent application refused [chapter 9.2 patent gazette]
B09B Patent application refused [chapter 9.2 patent gazette]

Free format text: MANTIDO O INDEFERIMENTO UMA VEZ QUE NAO FOI APRESENTADO RECURSO DENTRO DO PRAZO LEGAL

B350 Update of information on the portal [chapter 15.35 patent gazette]